Remove 2022 Remove Immunity Remove Immunization
article thumbnail

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

Pharmacy Times

The vaccine showed superior immune response for unique serotypes compared to PPSV23, with higher OPA titers. SHOW MORE In a phase 3 trial, V116 demonstrated significant immunogenicity in older adults who had not before received a pneumococcal vaccination. 1 Older adults are at increased risk of invasive pneumococcal disease.

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Washington, DC, USA - June 24, 2022: The symbol of the U.S. Kennedy Jr. Press Release.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Govt provides updates on measures to encourage domestic manufacturing

Express Pharma

15,000 crores and a production tenure from FY 2022- 2023 to FY 2027-28, provides financial incentives to 55 selected applicants for manufacturing of identified products under three categories for six years. The scheme provides financial incentives for the manufacturing of notified products. are manufactured. An incentive amount of Rs.3,215

article thumbnail

Actithera draws new investors to radiopharma drug pitch

BioPharma Dive

billion since 2022 from a group of 23 venture firms tracked by BioPharma Dive. It’s a way to dismantle a critical barrier to immune and therapeutic access,” he wrote in an email to BioPharma Dive. Other large companies, like Bristol Myers Squibb and Eli Lilly , have entered the field with acquisitions of earlier-stage public biotechs.

article thumbnail

Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning

Pharmacy Times

prevalence of hypercholesterolemia and about a quarter of US adults harbored elevated low-density lipoprotein cholesterol (LDL-C) levels from 2017 to 2022. The American Heart Association’s 2023 Heart Disease and Stroke Statistics Update found a 34.7%

article thumbnail

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

Expanded warnings include interactions with CNS depressants and rare outcomes like esophageal dysfunction, aligning with CDC's 2022 opioid prescribing guidelines. Labels now emphasize the risks of higher doses and caution against abrupt discontinuation in dependent patients to prevent withdrawal and other harms.

article thumbnail

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

Image Credit: Elena | stock.adobe.com A 2022 study reported that approximately 90% of the United States population lives within 5 miles of a pharmacy. The lack of access to immunization services may lead to lower vaccination rates and vulnerabilities to infectious diseases in these communities.